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Introduction
Urinary incontinence (UI) is defined as involuntary loss of 
urine, which is a social or hygienic problem according to the 
International Continence Society [1]. UI is considered as a 
chronic disease with a high incidence [2]. Stress urinary incon-
tinence (SUI) is UI that occurs suddenly owing to increased ab-
dominal pressure from exercises, sneezing, or coughing. This 
is because the pressure on the bladder, which is increased by 
abdominal pressure, is higher than the pressure of the urethral 
sphincter, which prevents urine leakage. SUI can be managed 
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Objective 
To examine the clinical outcome of obesity in women who underwent the transobturator tape procedure for stress 
urinary incontinence and to compare postoperative urinary symptoms after transobturator tape surgery between 
normal-weight women and overweight and obese women.
Methods
We performed a retrospective cohort study of the risk of postoperative urinary symptoms, including recurrence 
after transobturator tape surgery, in normal-weight women compared with overweight and obese women at our 
institution from January 2009 through October 2011. We compared the body mass index (BMI) among the four 
groups. The primary outcome was the occurrence of postoperative urinary symptoms.
Results
Three hundred ten patients who underwent transobturator tape surgery were reviewed. At the 1-year follow-up, 281 
women were analyzed: 89 (34%) normal-weight women, 78 (25%) overweight women, 101 (37%) obese 1 women, 
and 13 (3%) obese 2 women. There was a significant difference in the occurrence of postoperative urinary symptoms. 
They occurred in 3.4% (n=3) of normal-weight women, 5.1% (n=4) of overweight women, and 12.9% (n=13) of obese 
1 women (P=0.038). The most common postoperative urinary symptom was frequent urination (n=14). There was 
a significant difference in leakage; it occurred in 1.1% (n=1) of normal-weight women, 3.9% (n=3) of overweight 
women, and 7.9% (n=8) of obese 1 women (P=0.139). Postoperative urinary symptoms were almost four times more 
likely to occur in obese 1 women than in normal-weight women.
Conclusion
Transobturator tape surgery seems effective regardless of BMI, but obese women had a higher occurrence of 
postoperative urinary symptoms than did normal-weight women.
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conservatively, mechanically, pharmacologically, or surgically. 
Among the surgical treatments of SUI, the midurethral sling, 
which was introduced in 1996, is the most common type of 
surgery used to correct SUI in a minimally invasive manner. 
After the tension-free vaginal tape (TVT) was introduced, 
it became widely used in surgery for SUI [3]. TVT is used in 
simple procedures, and it is associated with few complica-
tions, such as occlusive nerve injury, retropubic hematoma or 
abscess, chronic urinary retention, vaginal wall and urethral 
erosion, and colorectal injury. To reduce the risk of these com-
plications, the transobturator tape (TOT) procedure, in which 
the tape is passed through the obturator foramen, was intro-
duced [4].
The prevalence of UI increases with age and for woman 
who have had previous births. In addition, the prevalence of 
UI is higher in women who have had previous vaginal deliv-
ery than in those who have undergone cesarean section [5]. 
Studies have shown that smoking and caffeine may increase 
the risk for incontinence [6]. Obesity is also a well-known risk 
factor for UI that affects the progression and recurrence of 
disease [7]. Obese status may lead to increased abdominal 
pressure [8] and cause UI by compressing the bladder. Ad-
ditionally, obesity may cause increased intra-abdominal pres-
sure and expose the pelvic support structures and organs to 
a chronic state of stress, and pelvic floor muscle fatigue may 
develop secondary to this increased pressure [9]. The purposes 
of this study were to examine the clinical outcome of obesity 
in women who underwent the TOT procedure for SUI, and to 
compare the differences in postoperative urinary symptoms 
between average-weight women and obese and overweight 
women.
Materials and methods
This retrospective cohort study was conducted in patients 
who underwent the TOT procedure for SUI at the Department 
of Obstetrics and Gynecology of Yonsei University Severance 
Hospital from January 2006 to October 2011. Patients who 
received follow-up care less than 1 year or previously under-
went incontinence surgery were excluded from this study.
The primary outcome was the occurrence of urinary symp-
toms. Patients’ characteristics were obtained by review of 
their medical records.
Patients were requested to report the presence of urinary 
symptoms, including leakage, frequency, urgency, voiding dif-
ficulty, hesitancy, post-void residual urine, constipation, and 
dyspareunia, preoperatively in the outpatient clinic. Obstet-
ric history such as the times of delivery, menopausal status, 
and history of hormone therapy were also reported by the 
patients. Moreover, a physical examination was conducted 
to confirm anatomical and nerve abnormalities. All patients 
underwent pelvic examination by a physician in the lithotomy 
position to evaluate pelvic organ prolapse, including uterine 
prolapse, enterocystocele, and proctocele. We performed 
a stress test, measured urethral hypermobility using the Q-
tip test, and conducted a urodynamic study in all patients. 
Patients who were diagnosed as having stress incontinence 
through the urodynamic study underwent the TOT procedure. 
The TOT used in the surgery was the Gynecare TVT Obturator 
System (Johnson and Johnson, New Brunswick, NJ, USA).
Body mass index (BMI) was calculated as the patient’s 
weight in kilograms divided by the patient’s height in me-
ters, squared. Patients were divided into four groups accord-
ing to BMI: normal weight (BMI, 18.5 kg/m2), overweight 
(BMI, 23.0 kg/m2), obese 1 (BMI, 25.0 kg/m2), and obese 2 
(BMI, 30.0 kg/m2 or higher). We compared the risk of post-
operative outcomes after the TOT surgery among the four 
groups. For BMI 30.0 or over, the number of patients were 
small but it was acknowledged to be more meanigful to ana-
lyze by caterotizing the patients as severe obese.
Postoperative follow-up interviews were performed to 
evaluate patients’ postoperative status. After the TOT proce-
dure, patients answered the question items and confirmed 
their status of urinary leakiness, frequency, urgency, voiding 
difficulty, hesitancy, post-void residual urine, constipation, and 
dyspareunia. Patients complaining of urinary symptoms post-
operatively were followed up after prescription of medication 
depending on their symptoms. Data was analyzed by χ2 test, 
Fisher’s exact test and reported as a value of number (%).
This study was approved by a certified Institutional Review 
Board, at Human Research Protection Center, Yonsei Univer-
sity Severance Hospital (assignment number: 4-2017-0573).
Results
From January 2006 to October 2011, we reviewed 310 pa-
tients who were diagnosed as having SUI and underwent the 
TOT procedure at the Department of Obstetrics and Gynecol-
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ogy of Yonsei University Severance Hospital. Among these pa-
tients, 281 received the follow-up care for more than 1 year. 
Eighty-nine (34%) patients were classified as normal weight 
(BMI, 18.5–22.9 kg/m2), 78 (25%) as overweight (BMI, 23.0–
24.9 kg/m2), 101 (37%) as obese 1 (BMI, 25.0–29.9 kg/m2), 
and 13 (3%) as obese 2 (BMI, 30.0 kg/m2 or higher). There 
was no significant difference in patients’ age, the menopausal 
status at the time of surgery, and whether they had received 
previous hormone therapy between the groups. There was 
also no significant difference in the type of delivery, namely 
vaginal parity, status of home delivery, and status of difficult 
labor between the four groups (Table 1). Patients in all groups 
reported that their symptoms improved postoperatively. None 
of the patients required reoperation because of postoperative 
urinary symptoms.
Regarding postoperative urinary symptoms, the obese 
group had a higher occurrence rate than the other groups. 
Postoperative urinary symptoms, including urine leakage, 
frequency, urgency, voiding difficulty, hesitancy, weak stream, 
post-voiding residual urine, and dyspareunia, occurred in 3.4% 
(n=3) of normal-weight women, 5.1% (n=4) of overweight 
women, and 12.9% (n=13) of obese 1 women (P=0.038) 
(Table 2). The risk of postoperative urinary symptoms after 
TOT surgery was almost four times more likely to occur in the 












(BMI, 30.0 kg/m2 
or higher; n=13)
P-value
Age (yr) 58.4±11.1 57.1±10.2 60.3±10.9 60.6±9.4 0.218
Menopause 58 (65.2) 62 (79.5) 75 (74.3) 10 (76.9) 0.202
HRT 3 (3.4) 2 (2.6) 4 (3.9) 0 (0.0) 0.946
Past history
HTN 65 (73.0) 48 (61.5) 53 (52.5) 5 (38.5) 0.010
DM 8 (8.9) 8 (10.3) 14 (13.9) 3 (23.1) 0.413
Prior hysterectomy 1 (6.7) 10 (12.8) 12 (11.9) 3 (23.1) 0.270
Delivery type
Vaginal deliver 2.5±1.2 2.6±1.1 2.9±1.3 3.2±2.3 0.171
Home delivery 25 (28.1) 24 (30.8) 38 (37.6) 5 (38.5) 0.513
Difficult labor 32 (35.9) 28 (35.9) 41 (40.6) 5 (38.5) 0.899
Types of concomitant surgery
Anterior repair 0 (0.0) 2 (2.6) 4 (3.9) 0 (0.0) 0.249
Posterior repair 11 (12.4) 12 (15.4) 11 (10.9) 3 (23.1) 0.580
TAH 5 (5.6) 4 (5.1) 7 (6.9) 1 (7.7) 0.881
Perineorrhaphy 39 (43.8) 47 (57.7) 42 (41.6) 3 (23.2) 0.046
Values are presented as number (%) or mean±standard deviation.
BMI, body mass index; HRT, hormone replacement therapy; HTN, hypertension; DM, diabetes mellitus; TAH, total abdominal hysterectomy.












(BMI, 30.0 kg/m2 
or higher; n=13)
P-value
Postoperative urinary symptoms 3 (3.4) 4 (5.1) 13 (12.9) 0 (0.0) 0.038
Urine leakage 1 (1.1) 3 (3.9) 8 (7.9) 0 (0.0) 0.139
Frequency 3 (3.4) 2 (2.6) 9 (8.9) 0 (0.0) 0.211
Urgency 2 (2.3) 2 (2.6) 4 (3.9) 0 (0.0) 0.878
Values are presented as number (%).
BMI, body mass index.
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obese 1 group than in the normal-weight group (odds ratio, 
4.235; P=0.028) (Table 3).
Discussion
SUI has a significant effect on the quality of life and mental 
aspects of women. We found that postoperative urinary 
symptoms after TOT procedure are more likely to occur in 
overweight women than in normal-weight women. The in-
crease of BMI is closely related to the increase in abdominal 
pressure, and obesity has a significant effect on the recurrence 
of SUI [10]. Subak et al. [11] conducted a 6-month weight 
loss program for overweight and obese women with urinary 
leakage symptoms. The authors concluded that 226 women 
with an average weight loss of 8.0% experienced a 47% re-
duction in the episodes of incontinence. It was suggested that 
weight loss in overweight and obese women can be helpful in 
reducing the symptoms of UI [11]. Auwad et al. [12] revealed 
that if obese women lose 5% of their body weight, they can 
experience significant improvement in UI and quality of life. 
However, further research is needed to confirm whether de-
creasing one’s weight after the TOT procedure will help lower 
the recurrence of postoperative urinary symptoms. Addition-
ally, in our study, there were more urinary symptoms after 
the TOT procedure in obese patients. Further, these patients 
should be studied to compare the improvement of urinary 
symptoms before and after weight management.
According to Cummings et al.’s statement [13], the sling op-
eration is a good surgical treatment for morbidly obese wom-
en. Likewise, in our study, the patients showed improvement 
of symptoms of SUI, and no patients required reoperation 
after TOT surgery. However, a study conducted by Hellberg et 
al. [14] showed that morbidly obese women who underwent 
the TVT procedure for SUI were more likely to experience un-
favorable results. As obesity increases, the cure rate is more 
likely to decrease. In a study of 970 patients who underwent 
the TVT procedure, 291 with normal weight had a cure rate 
of 81.2%; in contrast, only 61 morbidly obese woman (BMI 
>35.0 kg/m2) had a cure rate of 52.1% [14]. The authors 
found that obese women had more urinary symptoms post-
operatively when compared with the normal-weight women. 
In our study, postoperative urinary symptoms were significant-
ly more frequent in obese patients than in the other patients, 
but there was no difference in each of the three symptoms, 
i.e., urine leakage, frequency, and urgency.
The strength of this study is that we observed the postop-
erative urinary symptoms of the patients who underwent the 
TOT procedure for SUI within 1 year postoperatively. Until 
now, no researchers have followed up on the symptoms of 
patients for months and compared the symptom occurrence 
before and after surgery. We compared the occurrence of 
postoperative urinary symptoms between levels of obesity. 
The limitation of this study is that the number of patients with 
BMI >30.0 kg/m2 was substantially lower than the number of 
patients in the other BMI groups; therefore, it is difficult to 
make comparisons among morbidly obese women.
In conclusion, TOT seems to be a good treatment choice for 
SUI regardless of the patient’s BMI. This study’s findings indi-
cate that if patient undergoing the TOT procedure is obese, 
urinary symptoms are more likely to occur frequently after 
surgery. Weight reduction before the TOT procedure can im-
prove patients’ postoperative urinary symptoms. 
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